Immediate Impact
5 standout
Citing Papers
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
2022 Standout
Works of Ravi Ojha being referenced
Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein
2022
Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ravi Ojha | 56 | 27 | 17 | 7 | 84 | |
| Joseph W. Guarnieri | 68 | 45 | 28 | 7 | 124 | |
| Victoria Zaksas | 47 | 34 | 21 | 6 | 98 | |
| Qihong Yan | 91 | 43 | 31 | 10 | 170 | |
| Jason Hsu | 89 | 54 | 12 | 9 | 154 | |
| Lauren Baracco | 65 | 31 | 9 | 9 | 93 | |
| Mohammed Shahraz | 64 | 99 | 14 | 7 | 177 | |
| Qiaoxing Liang | 55 | 96 | 17 | 11 | 175 | |
| Amy Lacroix | 59 | 77 | 10 | 6 | 191 | |
| Tuuli Reisberg | 48 | 31 | 8 | 6 | 124 | |
| Sarah N. Zvornicanin | 76 | 79 | 23 | 6 | 140 |
All Works
Login with ORCID to disown or claim papers
Loading papers...